Work

Activity of BIBW 2992, an oral irreversible EGFR/HER2 dual kinase inhibitor, in combination with weekly paclitaxel in non-small cell lung cancer

Year: 2009

Type: article

Source: Research Portal (King's College London)

Authors: Flora Stavridi, Rebecca Kristeleit, Martin Förster, J.E. Ang, S. Rudman, Martina Uttenreuther‐Fischer, Karine Pemberton, Mehdi Shahidi, Johann S. de Bono, James Spicer

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2897894344

FWCI: 0.838

Cites:

Cited by: 4

Related to: 10